This is an article ( "Predicting cardiovascular complications in type 1 and 2 diabetes") published/written by the Staff that works for the Medivizor website. "It examines whether the levels of two different proteins could predict blood vessel damage in types 1 and 2 diabetes."
Predicting cardiovascular complications in type 1 and 2 diabetes
Patients with type 1 or type 2 diabetes have elevated levels of glucose (sugar) in their blood, either due to a lack of, or decreased sensitivity to, insulin (the hormone that breaks down the glucose taken in from food).
A common complication in both type 1 and 2 diabetes is damage to the large and small blood vessels. Large vessel damage can lead to coronary artery disease or stroke (plaque build-up in the coronary arteries of the heart), while small vessel damage can lead to nephropathy (kidney disease), neuropathy (nerve damage) or retinopathy (damage to the eye). Other factors in diabetes are also involved in the development of vessel damage, including the soluble endothelial protein C receptor (sEPCR) and high-sensitivity C reactive protein (hsCRP). Both of these proteins are involved in inflammation (the body’s response to harm, including damaged tissue), and levels may reflect the early stages of cardiovascular disease.
This study concluded that patients with diabetes, both type 1 and 2, have higher levels of these two types of proteins compared to healthy subjects, and these can possibly be used to predict both large and small blood vessel complications.
This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment.